VHCP Management as of Sept. 30, 2012
Portfolio Holdings for VHCP Management
VHCP Management holds 17 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals (IRWD) | 20.9 | $31M | 2.4M | 12.78 | |
| Neurocrine Biosciences (NBIX) | 14.6 | $21M | 2.7M | 7.98 | |
| Medivation | 9.7 | $14M | 253k | 56.35 | |
| Ym Biosciences | 7.4 | $11M | 5.9M | 1.84 | |
| Anacor Pharmaceuticals In | 7.2 | $11M | 1.6M | 6.58 | |
| GTx | 6.7 | $9.7M | 2.1M | 4.58 | |
| Tesaro | 6.4 | $9.3M | 657k | 14.23 | |
| ACADIA Pharmaceuticals (ACAD) | 5.8 | $8.5M | 3.4M | 2.53 | |
| Repros Therapeutics | 3.8 | $5.5M | 364k | 15.23 | |
| Threshold Pharmaceuticals | 3.4 | $5.0M | 684k | 7.24 | |
| Chelsea Therapeutics International | 2.8 | $4.1M | 3.4M | 1.20 | |
| Spectrum Pharmaceuticals | 2.8 | $4.1M | 350k | 11.70 | |
| Biodel | 2.6 | $3.8M | 1.3M | 2.97 | |
| NPS Pharmaceuticals | 2.0 | $2.9M | 315k | 9.25 | |
| Alexza Pharmaceuticals | 1.5 | $2.2M | 500k | 4.40 | |
| Keryx Biopharmaceuticals | 1.4 | $2.1M | 754k | 2.82 | |
| Anthera Pharmaceuticals | 1.0 | $1.4M | 1.4M | 0.99 |
